Stockpolly
Search
Delisting risk
CNTX · NASDAQ · Biotechnology

Context Therapeutics (CNTX)

Develops CD3-directed bispecific antibodies for solid tumors.

$0.3517
Pre-market−0.01 (−4.01%)
At close$0.3664(+0.58%)
Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions61 holders · as of Mar 31, 202680.73%74.18M shares
Insiders3 holders · as of Jun 10, 20251.23%1.13M shares
Otherremainder18.04%16.57M shares

91.88M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Bioimpact Capital LLCInstitution
11.62%10.68M13Fas of Mar 31, 2026
Deep Track Capital, LPInstitution
8.08%7.42M13Fas of Mar 31, 2026
Nextech Invest, Ltd.Institution
8.08%7.42M13Fas of Mar 31, 2026
Soleus Capital Management, L.P.Institution
7.58%6.96M13Fas of Mar 31, 2026
Soleus Capital Master Fund, L.P.Institution
7.58%6.96M13Gfiled May 8, 2026 ↗
Octagon Capital Advisors LPInstitution
5.71%5.25M13Fas of Mar 31, 2026
Blue Owl Capital Holdings LPInstitution
5.54%5.09M13Fas of Mar 31, 2026
Avidity Partners Management LPInstitution
5.44%5.00M13Fas of Mar 31, 2026
Franklin Resources IncInstitution
4.14%3.80M13Fas of Mar 31, 2026
Vanguard Capital Management LLCInstitution
3.74%3.43M13Fas of Mar 31, 2026
Marshall Wace, LLPInstitution
3.21%2.95M13Fas of Mar 31, 2026
TCG Crossover Management, LLCInstitution
2.92%2.68M13Fas of Mar 31, 2026
Great Point Partners LLCInstitution
2.44%2.24M13Fas of Mar 31, 2026
Millennium Management LLCInstitution
1.55%1.42M13Fas of Mar 31, 2026
Squadron Capital Management LLCInstitution
1.20%1.10M13Fas of Mar 31, 2026
Susquehanna International Group, LLPInstitution
1.19%1.09M13Fas of Mar 31, 2026
Martin A. Lehr1Insiderdirector, officer: Chief Executive Officer
1.11%1.02MForm 4filed Jun 10, 2025 ↗
Adage Capital Partners GP, L.L.C.Institution
1.09%1.00M13Fas of Mar 31, 2026
Sio Capital Management, LLCInstitution
1.00%917,92213Fas of Mar 31, 2026
BlackRock, Inc.Institution
0.92%846,69613Fas of Mar 31, 2026
Geode Capital Management, LLCInstitution
0.66%603,76713Fas of Mar 31, 2026
Cormorant Asset Management, LPInstitution
0.58%529,55013Fas of Mar 31, 2026
Jane Street Group, LLCInstitution
0.48%436,93113Fas of Mar 31, 2026
Adar1 Capital Management, LLCInstitution
0.38%351,09413Fas of Mar 31, 2026
Vanguard Fiduciary Trust CoInstitution
0.37%341,34413Fas of Mar 31, 2026
  1. Reported at 2.10% on Feb 12, 2025, under the 5% line, so no further filing is required.

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

61 holders · 74.18M shares · 26 new positions · 36 increased · 13 reduced · 8 closed

HolderShares% outstandingChg q/qFiled
Bioimpact Capital LLC10.68M11.62%0May 15, 2026
Deep Track Capital, LP7.42M8.08%0May 15, 2026
Nextech Invest, Ltd.7.42M8.08%0May 15, 2026
Soleus Capital Management, L.P.6.96M7.58%+6.96MnewMay 14, 2026
Octagon Capital Advisors LP5.25M5.71%+5.25MnewMay 15, 2026
Blue Owl Capital Holdings LP5.09M5.54%−2.34MMay 14, 2026
Avidity Partners Management LP5.00M5.44%−506.6KMay 28, 2026
Franklin Resources Inc3.80M4.14%−200.0KMay 13, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
MPM BioImpact LLC11.60%10.68M13GFeb 17, 2026 ↗
Avidity Partners Management LP8.70%8.30M13GMay 12, 2026 ↗
Deep Track Capital, LP8.27%7.42M13GMay 15, 2025 ↗
Soleus Capital Master Fund, L.P.7.60%6.96M13GMay 8, 2026 ↗
BlackRock, Inc.6.70%6.17M13GJul 27, 2026 ↗
Octagon Capital Advisors LP5.70%5.25M13GMay 14, 2026 ↗
Blue Owl Capital Holdings LP5.54%5.09M13GMay 14, 2026 ↗

Insider tradesForm 4

Latest trades

No open-market trades in the last 12 months.

CongressHouse and Senate disclosures

Not reported.